Education
About Us
Working with TipRanks
Follow Us
ProstaLund AB (SE:PLUN)
:PLUN
PLUN Stock Chart & Stats
kr0.40
-kr0.55(-9.73%)
At close: 4:00 PM EST
kr0.40
-kr0.55(-9.73%)
Day’s Range― - ―
52-Week Rangekr0.34 - kr14.20
Previous CloseN/A
Volume452.00
Average Volume (3M)486.70K
Market Cap
kr1.33M
Enterprise Valuekr6.80M
Total Cash (Recent Filing)kr2.41M
Total Debt (Recent Filing)kr3.41M
Price to Earnings (P/E)―
Beta0.44
Next Earnings
Nov 07, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.80
Shares Outstanding3,624,052
10 Day Avg. Volume103,970
30 Day Avg. Volume486,699
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
PLUN FAQ
What was ProstaLund AB’s price range in the past 12 months?
ProstaLund AB lowest stock price was kr0.34 and its highest was kr14.20 in the past 12 months.
What is ProstaLund AB’s market cap?
ProstaLund AB’s market cap is kr1.33M.
When is ProstaLund AB’s upcoming earnings report date?
ProstaLund AB’s upcoming earnings report date is Nov 07, 2025 which is in 14 days.
How were ProstaLund AB’s earnings last quarter?
ProstaLund AB released its earnings results on Aug 21, 2025. The company reported -kr1.802 earnings per share for the quarter, missing the consensus estimate of N/A by -kr1.802.
Is ProstaLund AB overvalued?
According to Wall Street analysts ProstaLund AB’s price is currently Overvalued.
Does ProstaLund AB pay dividends?
ProstaLund AB does not currently pay dividends.
What is ProstaLund AB’s EPS estimate?
ProstaLund AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ProstaLund AB have?
ProstaLund AB has 3,624,052 shares outstanding.
What happened to ProstaLund AB’s price movement after its last earnings report?
ProstaLund AB reported an EPS of -kr1.802 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.961%.
Which hedge fund is a major shareholder of ProstaLund AB?
Currently, no hedge funds are holding shares in SE:PLUN
Company Description
ProstaLund AB
ProstaLund AB (PLUN) is a biotechnology company focused on developing innovative solutions for the treatment of prostate-related conditions, particularly benign prostatic hyperplasia (BPH). The company operates within the healthcare sector, specializing in medical devices and therapeutic solutions aimed at improving the quality of life for men experiencing urinary issues due to prostate enlargement. ProstaLund's core products include minimally invasive medical devices designed to alleviate symptoms associated with BPH, leveraging advanced technology to enhance patient outcomes and streamline surgical procedures.
Technical Analysis
Clinical Laserthermia Systems AB Class B
―
Prostatype Genomics AB
―
BrainCool AB
―
Scandinavian Real Heart AB
―
NextCell Pharma AB
―